Results 111 to 120 of about 4,284 (156)

Tryptophan metabolites exert potential therapeutic activity in graves' orbitopathy by ameliorating orbital fibroblasts inflammation and proliferation. [PDF]

J Endocrinol Invest
Yang W, Xu X, Xie R, Lin J, Hou Z, Xin Z, Cao X, Shi T.   +7 more
europepmc   +1 more source

Novel immunoinflammatory blood markers in Graves' orbitopathy: insights into activity and severity. [PDF]

BMJ Open Ophthalmol
Abounoori M, Pourazizi M, Bahmani Kashkouli M, Akha O, Jafari R, Movahedirad M.   +5 more
europepmc   +1 more source

Unilateral Graves' Orbitopathy in a Patient with Marine-Lenhart Syndrome: A case report. [PDF]

Sultan Qaboos Univ Med J
Alfutaisi A, Osman A, Al Siyabi ZS, Al Senani OS, Bahowairath F, Al Farqani A, Al Rasbi SK.   +6 more
europepmc   +1 more source

Elimination of oral foci of infection might lead to clinical improvement of Graves' orbitopathy. [PDF]

Graefes Arch Clin Exp Ophthalmol
Sawicka-Gutaj N, Stańska A, Stański M, Gruszczyński D, Zawalna N, Pochylski M, Ruchała M.   +6 more
europepmc   +1 more source

Ocular surface disease index in Graves' orbitopathy: a cross-sectional study. [PDF]

Front Endocrinol (Lausanne)
Maglionico MN, Lanzolla G, Figus M, Cosentino G, Comi S, Marinò M, Santini F, Posarelli C.   +7 more
europepmc   +1 more source

Impact of ibrutinib on inflammation in a mouse model of Graves' orbitopathy. [PDF]

Front Endocrinol (Lausanne)
Kim C, Park JH, Choi YJ, Jun HO, Chung JK, Park TK, Yoon JS, Yang JW, Jang SY.   +8 more
europepmc   +1 more source

Combining orbital intensity modulated radiation therapy with periorbital triamcinolone acetonide injection for Graves' orbitopathy. [PDF]

Int J Ophthalmol
Jian H, Ma RX, He WM.
europepmc   +1 more source

Butyrate Ameliorates Graves' Orbitopathy Through Regulating Orbital Fibroblast Phenotypes and Gut Microbiota. [PDF]

Invest Ophthalmol Vis Sci
Ouyang P, Qi J, Tong B, Li Y, Cao J, Wang L, Niu T, Qi X.   +7 more
europepmc   +1 more source

Long-term outcome of Graves' orbitopathy following treatment with sirolimus. [PDF]

J Endocrinol Invest
Comi S, Cosentino G, Lanzolla G, Menconi F, Maglionico MN, Posarelli C, Latrofa F, Rocchi R, Figus M, Santini F, Marinò M.   +10 more
europepmc   +1 more source

PDK2-enhanced glycolysis aggravates fibrosis via IL11 signaling pathway in Graves' orbitopathy. [PDF]

Front Immunol
Peng Z, Huang R, Gan L, Wang J, Li X, Ding J, Han Y, Wu J, Xue K, Guo J, Zhang R, Qian J, Ma R.   +12 more
europepmc   +1 more source